ABLINKS N V has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Russian Federation and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MATOSSIAN ROGERS ARPI, ALDER BIOPHARMACEUTICALS INC and TEDDER THOMAS F.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 11 | |
#2 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | IT methods for management | |
#5 | Medical technology | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Data processing systems | |
#6 | Fermentation | |
#7 | Microorganisms | |
#8 | Object sterilising | |
#9 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Silans Karen | 5 |
#2 | Paulson Andrea | 3 |
#3 | Loverejs Mark | 2 |
#4 | Fernandes Dzhejson E | 2 |
#5 | De Khard Khans | 2 |
#6 | Bajnaehrt Ehl S | 2 |
#7 | Vud Ehndrju M | 1 |
#8 | Dixon Daniel A | 1 |
#9 | Tobler Skott Andreas | 1 |
#10 | Khugenbum Khendrikus Renerus Jakobus Matteus | 1 |
Publication | Filing date | Title |
---|---|---|
RU2433139C2 | Nanobodiec tm for treatment of aggregation-mediated diseases | |
RU2524129C2 | Therapeutic polypeptides, homologues thereof, fragments thereof and application thereof for modulation of platelet-mediated aggregation | |
RU2455312C2 | Tumour necrosis factor alpha single domain antibodies, and use thereof |